Halozyme Therapeutics, Inc. (HALO)
108.64
+0.47
(+0.43%)
USD |
NASDAQ |
Aug 24, 16:00
108.64
0.00 (0.00%)
After-Hours: 19:56
Halozyme Therapeutics Total Liabilities (Quarterly) : 2.434B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.434B |
| March 31, 2026 | 2.453B |
| December 31, 2025 | 2.665B |
| September 30, 2025 | 1.717B |
| June 30, 2025 | 1.721B |
| March 31, 2025 | 1.714B |
| December 31, 2024 | 1.800B |
| September 30, 2024 | 1.665B |
| June 30, 2024 | 1.680B |
| March 31, 2024 | 1.664B |
| December 31, 2023 | 1.649B |
| September 30, 2023 | 1.643B |
| June 30, 2023 | 1.659B |
| March 31, 2023 | 1.634B |
| December 31, 2022 | 1.672B |
| September 30, 2022 | 1.768B |
| June 30, 2022 | 1.488B |
| March 31, 2022 | 901.99M |
| December 31, 2021 | 907.48M |
| September 30, 2021 | 903.75M |
| June 30, 2021 | 906.12M |
| March 31, 2021 | 898.99M |
| December 31, 2020 | 428.88M |
| September 30, 2020 | 425.04M |
| June 30, 2020 | 421.42M |
| Date | Value |
|---|---|
| March 31, 2020 | 434.31M |
| December 31, 2019 | 474.11M |
| September 30, 2019 | 125.00M |
| June 30, 2019 | 157.78M |
| March 31, 2019 | 169.06M |
| December 31, 2018 | 191.36M |
| September 30, 2018 | 204.77M |
| June 30, 2018 | 219.83M |
| March 31, 2018 | 230.40M |
| December 31, 2017 | 311.58M |
| September 30, 2017 | 284.76M |
| June 30, 2017 | 286.62M |
| March 31, 2017 | 285.27M |
| December 31, 2016 | 294.00M |
| September 30, 2016 | 294.49M |
| June 30, 2016 | 286.21M |
| March 31, 2016 | 279.62M |
| December 31, 2015 | 138.79M |
| September 30, 2015 | 126.94M |
| June 30, 2015 | 123.82M |
| March 31, 2015 | 121.58M |
| December 31, 2014 | 124.62M |
| September 30, 2014 | 124.69M |
| June 30, 2014 | 126.75M |
| March 31, 2014 | 130.94M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Incyte Corp. | 1.528B |
| Neurocrine Biosciences, Inc. | 1.666B |
| AVITA Medical, Inc. | 75.62M |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.577B |
| Shareholders Equity (Quarterly) | 143.54M |
| Debt to Equity Ratio | 14.95 |
| Current Ratio | 2.709 |
| Net Debt Paydown Yield | -1.43% |